Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs

Oct 08, 2020, 08:17 PM

In this episode of the Endocrine Outlook, listeners will hear a conversation with Muthiah Vaduganathan, MD, MPH, a cardiologist at Brigham and Women’s hospital. Vaduganathan was also the member of the writing committee for a recent AHA scientific statement regarding the cardionrenal protective benefits of SGLT2 inhibitors and GLP-1 receptor agonists.